DB

Dilbir S. Bindra

BS Bristol-Myers Squibb: 6 patents #867 of 3,969Top 25%
AA Astrazeneca Ab: 1 patents #1,022 of 1,971Top 55%
Merck: 1 patents #5,419 of 9,382Top 60%
📍 New Brunswick, NJ: #84 of 709 inventorsTop 15%
🗺 New Jersey: #11,005 of 69,400 inventorsTop 20%
Overall (All Time): #644,476 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
9233948 Pharmaceutical compositions comprising N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide Madhushree Yeshwant Gokhale, Cletus John Nunes, Ajit B. Thakur 2016-01-12
9198925 Pharmaceutical formulations containing an SGLT2 inhibitor Mandar V. Dali, Prakash V. Parab, Jatin M. Patel, Li Tao, Ravindra W. Tejwani +2 more 2015-12-01
8911785 Pharmaceutical compositions comprising N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-OXO-1,2-dihydropyridine-3-carboxamide Madhushree Yeshwant Gokhale, Cletus John Nunes, Ajit B. Thakur 2014-12-16
8716251 Pharmaceutical formulations containing an SGLT2 inhibitor Mandar V. Dali, Prakash V. Parab, Jatin M. Patel, Li Tao, Ravindra W. Tejwani +2 more 2014-05-06
8361972 Pharmaceutical formulations containing an SGLT2 inhibitor Mandar V. Dali, Prakash V. Parab, Jatin M. Patel, Li Tao, Ravindra W. Tejwani +2 more 2013-01-29
8221786 Pharmaceutical formulations containing an SGLT2 inhibitor Mandar V. Dali, Prakash V. Parab, Jatin M. Patel, Li Tao, Ravindra W. Tejwani +2 more 2012-07-17
7851502 Pharmaceutical formulations containing an SGLT2 inhibitor Mandar V. Dali, Prakash V. Parab, Jatin M. Patel, Li Tao, Ravindra W. Tejwani +2 more 2010-12-14
5733907 Prodrugs of an inhibitor of HIV protease Jose Alexander, Bruce D. Dorsey, Arnold J. Repta, Joseph P. Vacca 1998-03-31